Editorial & Columns
#Dr.AnilKumarAngrish Archive
Editorial & Columns
FY24 Review: Profitability of select Pharmaceutical Companies in India
Editorial & Columns
FY25: Deciphering Pharma Exports from India
Editorial & Columns
Asset Swapping or Asset Trade in Pharmaceutical Industry
Editorial & Columns
Insider or an Outsider as a CEO: Insights on Pharmaceutical Industry in India
Editorial & Columns
On the Right Side of Regulations: The USFDA and Indian Pharmaceutical Companies
Editorial & Columns
CSR by Pharmaceutical Companies and Engagement with SHGs, NGOs & Foundations
Editorial & Columns
Patent Cliff: Opportunity for Indian Pharmaceutical Companies
Editorial & Columns
Trump, Tariffs and Trade of Pharmaceuticals from India
Editorial & Columns